Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Bulletin Du Cancer|June 17, 2006
mTOR, Akt, S6 kinases and the control of skeletal muscle growthMario Pende
Frontiers in Cell and Developmental Biology|August 29, 2022
S6 kinase 1 at the central node of cell size and ageingStefano Fumagalli, Mario Pende
Molecular & Cellular Oncology|June 17, 2016
YAP enters the mTOR pathway to promote tuberous sclerosis complexNing Liang, Mario Pende
Rare Diseases (Austin, Tex.)|October 14, 2015
New insights into the pathophysiology of the tuberous sclerosis complex: Crosstalk of mTOR- and hippo-YAP pathways in cell growthPatricia E Dill, Ning Liang, Mario Pende
Annales D'Endocrinologie|April 10, 2013
The role of the mTOR pathway during liver regeneration and tumorigenesisGanna Panasyuk, Cecilia Patitucci, Catherine Espeillac, et al.
Biochemical Society Transactions|July 19, 2013
Role of PI3K, mTOR and Akt2 signalling in hepatic tumorigenesis via the control of PKM2 expressionIvan Nemazanyy, Catherine Espeillac, Mario Pende, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 13, 2010
Coordinated maintenance of muscle cell size control by AMP-activated protein kinaseLouise Lantier, Rémi Mounier, Jocelyne Leclerc, et al.
Biochemical Society Transactions|March 25, 2011
Regulation of the SREBP transcription factors by mTORC1Caroline A Lewis, Beatrice Griffiths, Claudio R Santos, et al.
Advances in Enzyme Regulation|November 25, 2010
Genetic ablation of S6-kinase does not prevent processing of SREBP1Caroline A Lewis, Beatrice Griffiths, Claudio R Santos, et al.
Molecular and Cellular Biology|August 2, 2012
The combined deletion of S6K1 and Akt2 deteriorates glycemic control in a high-fat dietCaroline Treins, Samira Alliouachene, Rim Hassouna, et al.
Pageof 6